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1. Introduction
Type 1 diabetes mellitus (type 1 diabetes, insulin-dependent diabetes mellitus), one of the
most common chronic diseases in childhood, is caused by insulin deficiency following auto-
immune destruction of the pancreatic beta cells. Until the one and only therapeutic option –
the life-long supplementation of insulin or its analogues – was established, affected children
died within a short time. Although extensive investigations on the pathogenesis of type 1
diabetes have been performed, the underlying causes and mechanisms are still far from be‐
ing completely understood. The consequence is a lack of prevention strategies or causal
therapies.
Great affords have been made to assess the incidence and prevalence of type 1 diabetes. The
epidemiology of type 1 diabetes is estimated with different methods ranging from small
cross-sectional studies to nationwide registries. Understanding the epidemiology of type 1
diabetes may identify risk factors, e.g. genetic predisposition or environmental factors, and
may thereby elucidate the pathogenesis of type 1 diabetes. This could be one way to estab‐
lish possible preventive or causal therapeutic strategies. However, the findings on the possi‐
ble trigger factors of type 1 diabetes and its epidemiology are sometimes controversial or
even contradictory.
In  the  present  chapter,  the  incidence  and prevalence  of  type  1  diabetes  during the  last
decades will be described. Some fundamental facts about the estimation of type 1 diabe‐
tes epidemiology may facilitate understanding. The epidemiologic patterns of type 1 dia‐
betes  regarding  geographic  differences,  gender  and  age  of  the  patients,  as  well  as
seasonal and ethnic factors in populations are summarized. The expected changes in type
1  diabetes  epidemiology  and  its  implications  on  future  research  directions  and  health
care are mentioned.
© 2013 Frese and Sandholzer; licensee InTech. This is an open access article distributed under the terms of
the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits
unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
2. Estimating the epidemiology of type 1 diabetes mellitus
The epidemiology of type 1 diabetes can be estimated in different ways. In principle, there is
the possibility of estimating epidemiologic data by self-report of the patients, longitudinal-
or cross-sectional studies or different-sized registries.
Data gained from self-reporting of diabetic patients have been shown to underestimate the
true burden of diabetes (Forouhi, Merrick et al. 2006). Another possibility, but with similar
limitations, is to assess data retrospectively (Mooney, Helms et al. 2004). Generally, longitu‐
dinal or cross-sectional studies are often locally or regionally performed. This limits the op‐
portunity to get generalizable results because the epidemiology of type 1 diabetes is known
to be heterogeneous regarding geography and ethnicity. Cross-sectional studies do not pro‐
vide information on the time-dependent changes of the epidemiology. Additionally, many
studies are limited to special settings, e.g. a general practice setting (Frese, Sandholzer et al.
2008), and although providing useful and necessary information, the reported data may not
be representative for the epidemiology of type 1 diabetes.
Especially when estimating the incidence of type 1 diabetes, the latency of onset until diag‐
nosis is important and influences the quality of estimated data. Also the validity of the chos‐
en diagnosis should be critically reviewed. In a recent German investigation, 60 (10.3%) of
580 patients were reclassified at mean 2.4 years after the diagnosis of type 1 diabetes: 23
(38.3%) as type 1 diabetes; 9 (15%) as maturity onset diabetes of the young; 20 (33.3%) as
"other specific diabetes forms", and 8 (13.3%) as "remission" of type 2 diabetes (Awa, Schob‐
er et al. 2011). The validity of the chosen diagnosis may differ depending on the data source
that affords a correct differential diagnosis, e.g. between type 1 diabetes and malnutrition
diabetes in developing countries or type 1 diabetes, type 2 diabetes and maturity onset dia‐
betes of the young in industrial countries, as well as a correct encoding of diagnosis. This is
because usual classification systems such as the International Classification of Primary Care
or International Classification of Diseases cannot be assumed to be sufficiently complete and
valid (Gray, Orr et al. 2003; Wockenfuss, Frese et al. 2009; Frese, Herrmann et al. 2012).
It is conclusive that reliable and valid – and thereby comparable – data on type 1 diabetes
epidemiology have to be based on a complete and detailed assessment. Disease registries
can be assumed to be probably the best method to estimate and manage standardized data.
However, the availability, completeness, quality and accuracy of diabetes registers are again
very variable (Forouhi, Merrick et al. 2006). Type 1 diabetes registries were established on
different levels: local (Howitt and Cheales 1993), regional (Galler, Stange et al. 2010), nation‐
al or multinational.
Much of our knowledge of the epidemiology of type 1 diabetes in young people has been
generated by large collaborative efforts based on standardized registry data: the EURODIAB
study in Europe and the DIAMOND project worldwide (Dabelea, Mayer-Davis et al. 2010).
In order to provide reliable information about the incidence and geographical variation of
type 1 diabetes throughout Europe, EURODIAB was established as a collaborative research
project (Fuller 1989; Green, Gale et al. 1992). During a 15-year period, 1989 to 2003, 20 popu‐
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lation-based EURODIAB registers in 17 countries registered 29,311 new cases of type 1 dia‐
betes in children before their 15th birthday (Patterson, Dahlquist et al. 2009). The World
Health Organization program, Multinational Project for Childhood Diabetes (Diabetes Mon‐
diale or DIAMOND), has been developed to investigate and characterize global incidence
and mortality of type 1 diabetes and the health care provided for type 1 diabetic patients.
Both projects used similar ascertainment methodologies. However, DIAMOND ascertained
some data retrospectively. This may have led to some underestimation of incidence rates.
The completeness of case ascertainment varied from 35 to 100% in DIAMOND. Most Euro‐
pean nations in DIAMOND had comparable (> 90%) rates of ascertainment to EURODIAB
(Vehik and Dabelea 2010). DIAMOND reached the lowest completeness rates in Africa, Cen‐
tral and South America. This reflects a general problem when assessing type 1 diabetes epi‐
demiology: data from developing countries are scarce and may not be fully representative
due to low rates of completeness.
3. The incidence of type 1 diabetes mellitus
This section provides a comprehensive description of type 1 diabetes incidence, its changes
over the last years, and its variability in populations and patient subgroups.
3.1. Geographic differences
Mean incidence rates of type 1 diabetes vary considerably depending on the geographic region
(Galler, Stange et al. 2010). The worldwide incidence of type 1 diabetes is described to vary by at
least 100- to 350-fold among different countries (Karvonen, Viik-Kajander et al. 2000). The high‐
est incidence rates are found in Finland and Sardinia (Italy) and the lowest in South American
countries, e.g. Venezuela and Brazil, and Asian countries, e.g. China or Thailand (Karvonen,
Viik-Kajander et al. 2000; Borchers, Uibo et al. 2010; Panamonta, Thamjaroen et al. 2011). Apart
from regions with low to intermediate incidence rates ranging between 5 and 20 per 100,000 chil‐
dren or adolescents per year, there are areas with incidence rates as high as 27 to 43 per 100,000
children or adolescents per year. Canada and Northern European countries, such as Finland and
Sweden, have the highest incidence rates ranging between 30 and 40 per 100,000 children/
adolescents per year. Incidence rates of countries in Central Europe (with the exception of Sardi‐
nia) vary from 8 to 18 per 100,000 children/adolescents per year. The incidence for type 1 diabetes
in German children aged 0 to 14 years was estimated at 13 per 100,000 per year for 1987–1998 and
at 15.5 per 100,000 per year for 1999–2003. The registry of the former German Democratic Repub‐
lic, which was kept from 1960 until 1989, reported incidence rates between 7 and 14 per 100,000
children/adolescents per year (Galler, Stange et al. 2010). In Mediterranean countries, the inci‐
dence rates of type 1 diabetes also show wide variations, although for some of them, there are still
no relevant and reliable data (Muntoni 1999). Summarizing the data on type 1 diabetes incidence,
the polar-equatorial gradient does not seem to be as strong as previously assumed. The incidence
of type 1 diabetes among different countries is presented in Table 1 and Table 2. When comparing
the incidence of type 1 diabetes between countries, it is important to keep the size of the sample
and the area of sampling in mind. This is because the incidence of type 1 diabetes may show
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strong variations among different regions from many countries as United States or Italy. Also a
Romanian study revealed a wide geographic variation (6.71-fold) between the highest and the
lowest incidence rates in different districts of the country (Ionescu-Tirgoviste, Guja et al. 2004).
While genetic factors are thought to explain some of the geographic variability in type 1 diabetes
occurrence, they cannot account for its rapidly increasing frequency. Instead, the declining pro‐
portion of newly diagnosed children with high-risk genotypes suggests that environmental
pressures are now able to trigger type 1 diabetes in genotypes that previously would not have de‐
veloped the disease during childhood (Borchers, Uibo et al. 2010). The importance of environ‐
mental factors towards manifestation of type 1 diabetes is also supported by migration studies:
For example a recently published study revealed that being born in Sweden, a country with high
type 1 diabetes incidence, increases the risk for type 1 diabetes in children with a genetic origin in
low-incidence countries (Soderstrom, Aman et al. 2012).
Country Sampling Region Incidence AI of Incidence
Algeria Oran 4.7 7.9 (1.85 to 14.00)
Australia West 14.9 6.3 (2.11 to 10.50)
Australiaa New South Wales 19.4 2.8 (1.9 to 3.8)
Canada Prince Edward Island 23.5 3.2 (-0.33 to 6.38)
Canada Montreal 9.3 1.6 (-0.67 to 3.82)
China Shanghai 0.7 7.4 (2.3 to 12.5)
Iceland n.s. 9.0 2.3 (-2.38 to 6.96)
Israel Yemenite Jews 5.0 3.2 (2.51 to 3.88)
Japan Hokkaido 1.7 5.9 (4.14 to 7.63)
Libya n.s. 8.7 6.3 (0.69 to 11.8)
New Zealand Auckland 10.1 6.4 (4.20 to 8.52)
New Zealand Canterbury 12.7 2.7 (.0.05 to 10.50)
Peru Lima 0.5 7.7 (-1.0 to 16.4)
Thailandb Northeast Thailand 0.6 n.s.
United Statesc Colorado 19.4 2.3 (1.6 to 3.1)
United States Hawaii 7.8 7.8 (1.8 to 14.9)
United States Allegheny County 14.7 1.5 (0.21 to 2.83)
United States Colorado 12.3 -0.2 (-2.52 to 2.19)
aTaplin, Craig et al. 2005
bPanamonta, Thamjaroen et al. 2011
cVehik, Hamman et al. 2007
n.s.: not sepcified
Table 1. The incidence (per 100,000 per year) of type 1 diabetes and its annual increase (AI; with 95% confidence
interval) in different non-European countries. If not otherwise indicated, data were adopted from the review of
Onkamo, Vaananen et al. (1999). The analyzed time period differed from country to country.
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Country Sample 1st period 2nd period AI
Austria whole nation 9.0 13.3 4.3 (3.3 to 5.3)
Belgium Antwerp 10.9 15.4 3.1 (0.5 to 5.8)
Bosniaa Tuzla canton 8.9 - 15 (6.0 to 25)
Croatiab two sources 6.9 - 9.0 (5.8 to 12.2)
Czech Republic whole nation 8.7 17.2 6.7 (5.9 to 7.5)
Denmarkc whole nation 22.0 - 3.4 (1.9 to 5.0)
Estoniad whole nation 10.1 16.9 3.3 (n.s.)
Finland two regions 39.9 52.6 2.7 (1.4 to 4.0)
Germany BadenWürttemberg 13.0 15.5 3.7 (2.9 to 4.5)
Germany Düsseldorf 12.5 18.3 4.7 (3.1 to 6.3)
Hungary 18 counties 8.8 11.5 2.9 (1.9 to 3.9)
Italye Sardinia 37.7 49.3 2.8 (1.0 to 4.7)
Lithuana whole nation 7.3 10.3 3.8 (2.2 to 5.3)
Luxembourg whole nation 11.4 15.5 2.4 (-1.4 to 6.3)
Maltaf n.s. 14.7 - 0.5 (-2.1 to 3.2)
Montenegrog whole nation 10.8 16.3 4.6 (0.4 to 9.6)
Norway eight counties 21.1 24.6 1.3 (0.1 to 2.6)
Poland Katowice 5.2 13.3 9.3 (7.8 to 10.8)
Romania Bucharest 4.7 11.3 8.4 (5.8 to 11.0)
Slovakia whole nation 8.2 13.6 5.1 (4.0 to 6.3)
Slovenia whole nation 7.9 11.1 3.6 (1.6 to 5.7)
Spain Catalonia 12.4 13.0 0.6 (-0.4 to 0.6)
Sweden Stockholm county 25.8 34.6 3.3 (2.0 to 4.6)
United Kingdom Northern Ireland 20.0 29.8 4.2 (3.0 to 5.5)
United Kingdom Yorkshire 17.1 22.4 2.2 (1.1 to 3.4)
United Kingdom Oxford 16.0 23.3 3.6 (2.6 to 4.6)
aStipancic, La Grasta Sabolic et al. 2008, 1995-2003
bTahirovic and Toromanovic 2007, 1995-2004
cSvensson, Lyngaae-Jorgensen et al. 2009, 1996-2005
dTeeaar, Liivak et al. 2010, 1983-1990 vs. 1999-2006
eCasu, Pascutto et al. 2004, 1989-1994 vs. 1995-1999
fSchranz and Prikatsky 1989, 1980-1987
gSamardzic, Marinkovic et al. 2010, 1997-2001 vs. 2002-2006
n.s.: not sepcified
Table 2. The incidence (per 100,000 per year) of type 1 diabetes and its annual increase (AI; with 95% confidence
interval) in different European regions. If not otherwise indicated, data were adopted from Patterson, Dahlquist et al.
(2009) and were estimated during the periods 1989-1993 and 1999-2003, respectively.
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3.2. Changes over the last years
A global rise in the incidence of type 1 diabetes in children and adolescents has been report‐
ed over the past decades (Onkamo, Vaananen et al. 1999; Karvonen, Viik-Kajander et al.
2000; Soltesz 2003; Aamodt, Stene et al. 2007; Soltesz, Patterson et al. 2007). The world-wide
annual increment of type 1 diabetes has already been summarized in the work of Onkamo,
Vaananen et al. (1999). They found a statistically significant increase of incidence in 65%
(24/37) of the examined populations. A non-statistically significant upward tendency was
seen in another 12 populations, while a statistically significant decrease of type 1 diabetes
incidence was not found. The global trend of the increase in the incidence of type 1 diabetes
was 3.0% per year (95% CI 2.59-3.33; p < 0.001; Onkamo, Vaananen et al. 1999).
The United States stood apart from other nations in reporting a stable incidence of child‐
hood type 1 diabetes in the 1970s through the 1990s (Vehik and Dabelea 2010). The multi‐
center Search for Diabetes in Youth Study (SEARCH) reported that the 2002 to 2005
incidence of type 1 diabetes in non-Hispanic White younger than 14 years of age was
27.5/100,000 per year (Bell, Mayer-Davis et al. 2009). This exceeded the incidence predicted
for 2010 by earlier data from Allegheny County, Pennsylvania (Dokheel 1993). A similar de‐
velopment was noticed by estimated data from Colorado (Vehik and Dabelea 2010).
For Europe, data from the EURODIAB-register suggest an annual increment of incidence of
about 0.6-15% (see Table 2 for details; Patterson, Dahlquist et al. 2009). Earlier data regard‐
ing type 1 diabetes incidence from all 36 EURODIAB-centers were published by Green and
Patterson (2001).
Regarding the strong differences in the annual increase in the incidence of type 1 diabetes
between the countries, it must be mentioned that, besides the geographic differences, the in‐
cidence trend was found not to be continuously linear. Furthermore, the incidence trend in‐
creases exponentially. Predictions made by Onkamo et al. for the incidence rates in 2010
pointed to large increases, but, in retrospect, were too conservative, especially regarding
younger children (Knip 2012).
3.3. Sex-dependent differences of type 1 diabetes mellitus incidence
Despite matched-pair investigations suggested that for some early childhood risk factors the
odds ratio in boys were different from those in girls (Svensson, Carstensen et al. 2005), most
of the published studies reported no significant difference between the type 1 diabetes inci‐
dence in boys and girls (Shaltout, Qabazard et al. 1995; Abellana, Ascaso et al. 2009; Svens‐
son, Lyngaae-Jorgensen et al. 2009; Samardzic, Marinkovic et al. 2010; Teeaar, Liivak et al.
2010). Other groups found small and thereby not relevant sex-related differences only for
subgroups (Shaltout, Qabazard et al. 1995). A sex-related difference in incidence was found
only in the 10- to 14-year age group with a significantly higher incidence in boys (18.77 vs.
14.7/100,000/year, p = 0.015; Bizzarri, Patera et al. 2010). However, a statistically significantly
higher incidence in girls was reported by a Libyan (Kadiki and Roaeid 2002), a Thai (Pana‐
monta, Thamjaroen et al. 2011), and an Australian group (Taplin, Craig et al. 2005). The lat‐
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ter also found the average annual increase of incidence to be significantly higher in boys
(3.8% vs. 1.9%, p = 0.046).
Taken together the reported studies suggest no sex-dependent differences in the incidence
of type 1 diabetes. Type 1 diabetes can be assumed to be the only major organ-specific auto‐
immune disease not to show a strong female bias. The overall sex ratio is roughly equal in
children diagnosed under the age of 15 years (Gale and Gillespie 2001). After the age of pub‐
erty, males are more frequently affected than females (Nystrom, Dahlquist et al. 1992).
3.4. Age-dependent differences of type 1 diabetes mellitus incidence
The following sections are intended to answer two questions: 1) does the incidence of type 1
diabetes differ between distinct age groups, and 2) what changes of the incidence of type 1
diabetes within these age groups occurred over the last years.
3.4.1. The age-dependent pattern of type 1 diabetes mellitus incidence
The incidence of type 1 diabetes shows an age-dependent pattern. It was reported to be sig‐
nificantly lower in the 0– to 4-year-old group than in the other groups (Bizzarri, Patera et al.
2010). Many studies from different countries reported an increase of the incidence with in‐
creasing age. The highest incidences were found in the 10 to 14-year-old age group (Karvo‐
nen, Viik-Kajander et al. 2000; Michaelis et al., 1993; Neu, Ehehalt et al. 2001; Taplin, Craig et
al. 2005; Samardzic, Marinkovic et al. 2010).
3.4.2. The increase of incidence in different age groups
The increasing incidence of type 1 diabetes is evident. Although some groups found no age-de‐
pendent differences in the annual increment of type 1 diabetes incidence (Taplin, Craig et al.
2005; Svensson, Lyngaae-Jorgensen et al. 2009; Abduljabbar, Aljubeh et al. 2010), the majority of
the published studies reported different increments of incidence after stratifying children and
youths into different age groups: Michealis et. al (1993) found an increment of incidence of about
12.6% in 0- to 9-year-old children, in 10- to 19-year-old children the increment was 3.8%. Similar
results were reported by other German groups (Neu, Ehehalt et al. 2001; Ehehalt, Blumenstock et
al. 2008): the relative increment of type 1 diabetes incidence was 5.7% per year in 0- to 4-year-old
children, the other age groups showed smaller increments. The incidence of childhood-onset
type 1 diabetes in Estonian children under 15 years of age increased annually by an average of
3.3% with the most rapid annual increase (9.3%) occurring in the youngest age group (Teeaar,
Liivak et al. 2010). The EURODIAB register repeatedly confirmed that in Europe the annual in‐
crease of incidence is higher in younger children (0 to 4 years of age; Green and Patterson 2001;
Patterson, Dahlquist et al. 2009).
3.5. Seasonal differences of type 1 diabetes mellitus incidence
When discussing seasonal differences in the epidemiology of type 1 diabetes, two different
aspects must be mentioned: 1) different frequency of type 1 diabetes regarding the season of
birth, and 2) the changing onset or diagnosis of type 1 diabetes through the year.
The Epidemiology of Type 1 Diabetes Mellitus
http://dx.doi.org/10.5772/52893
9
3.5.1. Seasonal changes in the incidence of type 1 diabetes mellitus
The seasonality of onset or diagnosis of type 1 diabetes has been extensively studied and the re‐
sults, so far, are conflicting (Moltchanova, Schreier et al. 2009). However, an increment of type 1
diabetes incidence during the winter has been reported by manifold studies (for details: Padaiga,
Tuomilehto et al. 1999) from different countries, e.g. Australia (Elliott, Lucas et al. 2010), the Unit‐
ed States (Gorham, Barrett-Connor et al. 2009), Chile (Durruty, Ruiz et al. 1979; Santos, Carrasco
et al. 2001), Sweden (Samuelsson, Carstensen et al. 2007; Ostman, Lonnberg et al. 2008), Norway
(Joner and Sovik 1981), Greece (Kalliora, Vazeou et al. 2011), and the Czech Republic (Cinek,
Sumnik et al. 2003). Recently, Jarosz-Chobot et al. (2011) reported that a significant increase in
type 1 diabetes incidence among children over 4 years of age was observed in the autumn–winter
season (p = 0.137 for the age group 0–4 years and p < 0.001 for the age groups 5-9 and 10-14 years).
These findings were confirmed by other studies in Poland (Pilecki, Robak-Kontna et al. 2003;
Zubkiewicz-Kucharska and Noczynska 2010). Other, partially incomparable, studies revealed
no seasonal pattern in the onset or diagnosis of type 1 diabetes mellitus (Levy-Marchal, Papoz et
al. 1990; Muntoni and Songini 1992; Ye, Chen et al. 1998) or reported seasonal changes only for
subgroups (Michalkova, Cernay et al. 1995; Douglas, McSporran et al. 1999; Padaiga, Tuomileh‐
to et al. 1999). Moltchanova et al. (2009) analyzed data from 105 centers in 53 countries: however,
only 42 centers exhibited significant seasonality (p < 0.05) in the incidence of type 1 diabetes when
the data were pooled for age and sex (Moltchanova, Schreier et al. 2009). Centers further away
from the equator were on average more likely to exhibit seasonality (p < 0.001). Although the ma‐
jority of the published data suggests seasonal-dependent changes in the incidence of type 1 dia‐
betes mellitus, further research is needed to complete the picture. Especially populations living
below the 30th parallel north should be studied, the populations themselves should be investi‐
gated more deeply, and the sample sizes should be increased to gain adequate power to detect
seasonal changes in low-incidence populations.
According to the published literature, the seasonal changes in the incidence of type 1 diabe‐
tes are likely to be caused by changes of the (auto-)immune activity. The first point is that a
reduced ultraviolet radiation exposure during the winter months may lead to reduced vita‐
min D levels. Thereby, the inhibitory effect of vitamin D on Th1-lymphocytes decreases. The
second point is the stimulation of the immune system especially by viral infections during
the winter months. The result of both could be a higher (auto-)immune activity that causes
ß-cell destruction.
3.5.2. Effects of the season of birth on the incidence of type 1 diabetes mellitus
Possible influences of the season of birth are discussed for many autoimmune diseases, e.g. mul‐
tiple sclerosis, Hashimoto thyreoditis, or Grave’s disease (Krassas, Tziomalos et al. 2007). Spring
births were associated with increased likelihood of type 1 diabetes, but possibly not in all United
States regions (Kahn, Morgan et al. 2009). An Egyptian group reported that 48.3% of diabetic chil‐
dren were delivered during summer months (Ismail, Kasem et al. 2008). A German investigation
showed children and adolescents with diabetes being significantly less often born during the
months April-June and July-September (Neu, Kehrer et al. 2000). This seasonality pattern was
different from those registered in Israel, Sardinia and Slovenia, in which the population with dia‐
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betes type 1 had most births during these months (1972; Neu, Kehrer et al. 2000). A Ukrainian
group found that type 1 diabetes was some 30% more common among persons born in April than
among persons born in December (Vaiserman, Carstensen et al. 2007). McKinney et al. analyzed
data from 19 European countries, but found no uniform seasonal pattern of birth in childhood
diabetes patients across European populations, either overall or according to sex and age
(McKinney 2001). Small Turkish studies did not reveal any significant differences of the season of
birth in type 1 diabetic vs. metabolically healthy children (Evliyaoglu, Ocal et al. 2002; Karaguzel,
Ozer et al. 2007). The controversial results might be explained by the composition of most study
samples: Laron et al. found a pattern in the seasonality of month of birth only in ethnically homo‐
genous populations (such as Ashkenazi Jews, Israeli Arabs, individuals in Sardinia and Canter‐
bury, New Zealand, and Afro-Americans), but not in heterogeneous populations (such as in
Sydney, Pittsburgh and Denver; Laron, Lewy et al. 2005). Thereby, it becomes likely that ethni‐
cally heterogeneous populations comprising a mixture of patients with various genetic back‐
grounds and environmental exposures mask the different seasonality pattern of month of birth
that many children with diabetes present when compared to the general population (Laron,
Lewy et al. 2005).
Authors describing a relationship between season of birth and susceptibility for type 1 dia‐
betes have attributed this to intrauterine infections, dietary intake of certain nutrients and
possible toxic food components, short duration of breastfeeding, early exposure to cows’
milk proteins, and vitamin D deficiency (Vaiserman, Carstensen et al. 2007). Since most of
these factors vary with season, one would expect a difference in the seasonal birth pattern
between the general population and those children who develop diabetes. A possible link
between environmental factors and type 1 diabetes mellitus manifestation was provided by
Badenhoop et al. They found HLA susceptibility genes to be in different proportions of pa‐
tients either born in different seasons of the year or having manifested their disease in differ‐
ent historical periods over time (Badenhoop, Kahles et al. 2009).
3.6. Ethnic differences
It has been proposed that much of the current variation in the incidence of type 1 diabetes is
due in part to differing distributions of ethnicity throughout the world. Many large studies
of type 1 diabetes have provided evidence that the ethnic background is one of the most im‐
portant risk factors for type 1 diabetes (Vehik and Dabelea 2010). It can be assumed that
there is a genetically founded – and thereby ethnically associated – varying susceptibility for
type 1 diabetes. The onset of the disease is then triggered by ubiquitous environmental fac‐
tors (Knip, Veijola et al. 2005; Knip and Simell 2012). In general, susceptibility to type 1 dia‐
betes is attributable to genes that link disease progression to distinct steps in immune
activation, expansion, and regulation (Nepom and Buckner 2012).
One half of the genetic susceptibility for type 1 diabetes is explained by the HLA (human
leukocyte antigen) genes (Knip and Simell 2012). It becomes conclusive that the main re‐
search focus is on ethnic variances in HLA-haplotypes and its association with type 1 diabe‐
tes (Lipton, Drum et al. 2011; Noble, Johnson et al. 2011). Based on the presence of two high-
risk HLA-DQA1/B1 haplotypes, an investigation in the United States revealed that
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Caucasians are at the highest and Latinos are at the second-highest risk for developing type
1 diabetes compared to all other ethnic groups (Lipton, Drum et al. 2011). However, there is
accumulating evidence that the proportion of subjects with newly diagnosed type 1 diabetes
and high-risk HLA genotypes has decreased over the last decades, whereas the proportion
of those with low-risk or even protective HLA genotypes has increased (Hermann, Knip et
al. 2003; Gillespie, Bain et al. 2004).
The second half of the genetic susceptibility for type 1 diabetes is caused by more than 50
non-HLA genetic polymorphisms (Knip and Simell 2012). Nowadays, there are more than
60 gene loci contributing to the susceptibility of developing type 1 diabetes (Morahan 2012),
but this overwhelming list of type 1 diabetes risk genes exerts little influence on the clinical
management of children that are at high risk. Conclusively, it is necessary to place the genet‐
ics of type 1 diabetes in a more amenable clinical context (Morahan 2012).
Despite the fact that there is consensus about the different genetic type 1 diabetes suscepti‐
bility among different ethnic groups, these differences cannot explain the complete variance
of type 1 diabetes incidence and prevalence. Furthermore, the annual increment of type 1
diabetes incidence cannot be explained by changing genetic susceptibility. Together with the
fact that many individuals are genetically highly susceptible for type 1 diabetes, it becomes
conclusive that environmental factors play a crucial role in the onset of the disease and its
epidemiology (Knip and Simell 2012).
4. The prevalence of type 1 diabetes mellitus
This section provides a comprehensive description of the type 1 diabetes prevalence, current
prevalence trends, and its variability depending among populations and individuals of dif‐
ferent age.
4.1. The geographic differences of type 1 diabetes mellitus prevalence
Banting and Best introduced the treatment of type 1 diabetes with insulin injections in the year
1922. Although their first patient (Leonard Thompson) died at the age of 27 from suspected pneu‐
monia, other patients, even from this first treatment series, lived a long time (Teddy Ryder died at
the age of 76, Jim Havens at the age of 59 and Elisabeth Ewans Hughes at the age of 73 years; Plis‐
ka, Folkers et al. 2005). This observation led to the assumption that the life expectancy of type 1 di‐
abetic patients may be near to normal if the disease is properly treated. It was proven that the life
expectation of type 1 diabetic patients has increased over the last decades (Ioacara, Lichiardopol
et al. 2009; Miller, Secrest et al. 2012). Therefore, it becomes conclusive that the changes in inci‐
dence imply similar trends in the prevalence rates of type 1 diabetes and lead to an accumulation
of the disease burden caused by type 1 diabetes and its complications. Recent studies suggest a
doubling of type 1 diabetes prevalence within a 20-year period (Akesen, Turan et al. 2011; Ehe‐
halt, Dietz et al. 2012). The International Diabetes Federation assumed that in 2011 about 490,100
children (aged 0 to 14 years) suffer from type 1 diabetes. This would correspond to a worldwide
prevalence of (25.8 per 100,000 children aged 0 to 4 years). Following the Diabetes Atlas (Interna‐
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tional Diabetes Federation 2011), there 116,100 cases of type 1 diabetes in the Europe, 64,900 in the
Middle East and North Africa region, 36,100 in the Africa, 94,700 in the North America and Carib‐
bean, 36,100 in the South and Central America, 111,500 in the South-East Asia and 30,700 in the
Western Pacific region. In accordance with incidence rates differing regionally within countries
and also among different countries, the prevalence of type 1 diabetes mellitus varies in a broad
range. The prevalence of type 1 diabetes in different countries is summarized in Table 3.
Country Sampling Period Prevalence
Finland 2000–2005 427.5
Sweden 2001–2005 270.5
Norway 1999–2003 182.4
United Kingdom 1989–2003 158.3
Canada 1990–1999 146.7
Denmark 1996–2005 141.2
Australia 1999–2008 137.8
United States 2002–2003 135.6
Germany 1989–2003 126.7
Netherlands 1996–1999 124.8
Czech Republic 1989–2003 117.5
New Zealand 1999–2000 115.9
Belgium 1989–2003 107.7
Ireland 1997 107.3
Austria 1989–2003 97.6
Portugal 1994–1998 95.5
Luxembourg 1989–2003 94.9
Slovak Republic 1989–2003 94.2
Iceland 1994–1998 91.1
Poland 1989–2003 85.7
France 1998–2004 84.5
Greece 1995–1999 80.2
Hungary 1989–2003 76.5
Spain 1989–2003 74.6
Switzerland 1991–1999 61.1
Italy 1990–1999 59.9
Turkey 1992–1996 19.8
Japan 1998–2001 15.7
Mexico 1990–1993 8.1
Korea 1990–1991 6.7
Table 3. The prevalence of type 1 diabetes in children younger than 15 years in different OECD countries. Data are
based on estimations of the International Diabetes Federation (2009) and related to 100,000 children (0 to 14 years of
age) of each country.
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4.2. The age-related differences of type 1 diabetes mellitus prevalence
Regarding age dependents phenomena of type 1 diabetes incidence (see section 3.4) it be‐
comes conclusive that 1) the prevalence of type 1 diabetes shows no sex-related differences
and increases with age due to accumulation of individuals suffering from the disease and 2)
the age-dependent increment of prevalence is not just linear but more likely exponential due
to an age-dependent increment of type 1 diabetes incidence. These assumptions have been
confirmed for example by the findings of the Australian Institute of Health and Welfare (see
Table 4) that were based on the Australian National Diabetes Register.
Age (years) Persons Prevalence
0 to 4 405 28.8 (26.0 to 31.6)
5 to 9 1,731 128.0 (122.0 to 134.1)
10 to 14 3,597 256.3 (247.9 to 264.7)
total 5,733 137.8 (134.2 to 141.4)
Table 4. The estimated prevalence (per 100,000 inhabitants of the respective age group with 95% confidence
interval) of type 1 diabetes among Australian children aged 0-14 years (Australian Institute of Health and Welfare
2011).
5. What the changing epidemiology implies for future research
The number of investigations concerning the epidemiology of type 1 diabetes is extensive.
However, the published results are controversial or even contradictory. There is consensus
about fundamental aspects, such as the increasing incidence and prevalence of type 1 diabe‐
tes. Thereby, it becomes clear that type 1 diabetes will become more and more of a burden.
Although most investigations and publications have been of high methodological quality,
they lack exact explanations of the described phenomena, and understanding the mecha‐
nisms and triggers of type 1 diabetes remains a mystery.
Future research should lead to improved methods of estimating the epidemiology of type 1
diabetes. Like this, more valid and thereby comparable data on type 1 diabetes epidemiolo‐
gy and risk factors have to be gained, but also more data on the epidemiology of type 1 dia‐
betes over the whole lifespan are definitely needed (Knip 2012). Furthermore, future
research may lead to a better understanding of the underlying pathogenesis of type 1 diabe‐
tes by complementing the results of descriptive epidemiology with those of 'aetiological' ep‐
idemiology (Knip 2012) including the assessment of suspected environmental triggers and
risk factors as well as genetic background of the assessed individuals. Conclusively, future
research on type 1 diabetes cannot exclusively be performed with population-based ap‐
proaches. Individualized approaches, e.g. metabolic profiling in both the pre-autoimmune
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period and the preclinical period (Oresic, Simell et al. 2008), may provide clues to environ‐
mental triggers, such as infections or dietary changes, which likely cause disturbances in the
intestinal microbiota and the immune system and contribute to the onset of type 1 diabetes.
Thereby, children/adolescents at a high risk may be identified and possibilities for preven‐
tion of type 1 diabetes may be detected.
In part promising therapeutic approaches to type 1 diabetes as immunotherapy, stem cell-,
β-cell- or islet of Langerhans-transplantation have to be assessed in future studies to find
causal therapeutic strategies (Chatenoud, Warncke et al. 2012; Li, Gu et al. 2012; McCall,
James Shapiro et al. 2012). Additionally, further research is needed in the field of chronic
type 1 diabetes and the detection and treatment of its complications. The role of genetics in
susceptibility to nephropathy, retinopathy and other diabetic complications still largely re‐
mains to be explored (Borchers, Uibo et al. 2010).
6. What the changing epidemiology implies for future health care
Until  now,  the treatment  of  type 1  diabetic  patients  has  been the duty of  pediatricians,
internal  specialists,  or  diabetologists.  The consultation prevalence  of  type 1  diabetic  pa‐
tients  in  the  general  practitioners’  consultation  hour  was  low  (Frese,  Sandholzer  et  al.
2008). However, if the present trends continue, a doubling of new cases of type 1 diabe‐
tes in European children younger than 5 years is predicted between 2005 and 2020, and
prevalent cases younger than 15 years will rise by 70% (Patterson, Dahlquist et al. 2009).
Adequate health-care resources to meet these children's needs should be made available
(Patterson, Dahlquist et al.  2009). It is important to ensure appropriate planning of serv‐
ices and that resources are in place to provide high-quality care for the increased num‐
bers  of  children  who  will  be  diagnosed  with  diabetes  in  future  years  (Patterson,
Dahlquist et al. 2009).
In  Germany,  the  costs  of  pediatric  diabetes  care  exceeded  €110  million  in  2007.  Com‐
pared with estimates from the year 2000, average costs per patient had increased by 20%
and direct total costs for German pediatric diabetes care by 47% (Bachle, Holl et al. 2012).
The treatment costs rose because of new therapeutic strategies and an increase in diabe‐
tes prevalence. This illustrates that type 1 diabetes will be an increasing challenge for fu‐
ture health care.
Regarding future health care, it should be kept in mind that elderly and old patients with
type 1 diabetes represent a growing population that requires thorough diabetes care. Espe‐
cially type 1 diabetic patients older than 60 years will suffer from a longer diabetes duration,
a doubled risk for severe hypoglycemia, and a higher percentage of cardiovascular compli‐
cations (Schutt, Fach et al. 2012). In order to provide an adequate health care service, treat‐
ment strategies for adults and elderly persons suffering from type 1 diabetes have to be
implemented in practice and the knowledge of involved physicians, especially general prac‐
titioners, has to be enhanced.
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7. Summary
Data on the epidemiology of type 1 diabetes are based on standardized registry data, such as the
Diabetes Mondiale (DIAMOND) Project worldwide and The Epidemiology and Prevention of
Diabetes (EURODIAB) study in Europe. Some countries provide national registers. Regional or
loco-regional registers as well as (cross-sectional) studies have added further data to the current
knowledge. Epidemiologic data from developing countries are scarce and may not be fully rep‐
resentative.
The incidence of type 1 diabetes varies up to 100-fold among different countries. The highest inci‐
dences are found in northern countries, especially Finland. The lowest incidence rates were re‐
corded in South American and Asian countries. When discussing type 1 diabetes incidence, also
strong variations within countries have to be regarded and care should be taken when generaliz‐
ing results from a regional sample to a general population. The incidence of type 1 diabetes in‐
creases worldwide exponentially. The mean of increment is 3.0% per year. Some assume that the
incidence of type 1 diabetes in 2020 will be twice that of the year 2000. Before the age of puberty
type 1 diabetes there is no sex-related difference in the incidence of type 1-diabetes. However
some early childhood risk factors show different odds for boys and girls and after puberty males
are more frequently affected by new onset of type 1 diabetes than females. Type 1 diabetes inci‐
dence increases with the age of the children/adolescents, but the annually increase of incidence is
higher in younger children and those with moderate genetic susceptibility. There is evidence for
a circannular variation with a peak of type 1 diabetes incidence during the winter months. Possi‐
ble effects of the season of birth have to be further investigated with attention to the genetic back‐
ground of assessed individuals. Genetic susceptibility explains some of the variation of type 1
diabetes incidence and prevalence with the highest risk in individuals with Caucasian or Latino
background. As supported by migration studies, the increasing incidence of type 1 diabetes illus‐
trates the importance of environmental risk factors as triggers of the disease.
Future research should focus on indentifying environmental and genetic risk factors of type 1
diabetes and its complications, preventive strategies and causal treatment options. The preva‐
lence, which doubled worldwide over the last decades, will increase further and type 1 diabetes
will shift more and more into the focus of general practitioners. It becomes conclusive that type 1
diabetes will be a burden for more and more patients and for the majority of health care systems.
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